April 12, 2016

Drug Discovery

Your most potent molecule may not be the one you should develop. That compound with picomolar binding affinity may be far too unstable or insoluble or metabolically labile to ever make it to market. PharmaDirections will help you set up a target product profile and use it to select the molecule with the best overall chance of success.

A series of studies ranging from in silico modeling to ADME and ‘druggability’ studies help us to select the best clinical candidate or to elucidate potential roadblocks in developing specific molecules.